43. Hernigou P, Poignard A, Beaujean F, Rouard H. Percutaneous
autologous bone-marrow grafting for nonunions. Inffuence of the number and
concentration of progenitor cells. J Bone Joint Surg Am. 2005; 87(7): 1430.
44. Giannotti S, Trombi L, Bottai V, et al. Use of Autologous human
mesenchymal Stromal cell/fibrin clot constructs in upper limb non-unions: long-
term
assessment.
PLoS
ONE.
2013;
8(8):
e73893.
doi:
10.1371/journal.pone.0073893.
45. Ripa RS, Haack-Sørensen M, Wang Y, et al. Bone marrow derived
mesenchymal cell mobilization by granulocyte-colony stimulating factor after
acute myocardial infarction: results from the stem cells in myocardial infarction
(STEMMI) trial. Circulation. 2007; 116(11_suppl): I–24–I–30.
46. Lamirault G, de Bock E, Roncalli J, et al. Sustained quality of life
improvement after intracoronary injection of autologous bone marrow cells in the
setting of acute myocardial infarction: Results from the BONAMI trial. Qual Life
Res. July 2016.
47. Chen SL, Fang WW, Ye F, et al. Effect on left ventricular function of
intracoronary transplantation of autologous bone marrow mesenchymal stem cell
in patients with acute myocardial infarction. Am J Cardiol 2004; 94: 92-95.
48. Choudry F, Hamshere S, Saunders N, et al. A randomized double-blind
control study of early intracoronary autologous bone marrow cell infusion in
acute myocardial infarction: the REGENERATEAMI clinical trial. Eur Heart J.
2015; 37(3): 256-263. doi: 10.1093/eurheartj/ehv493.
49. Peng L, Xie DY, Lin BL, et al. Autologous bone marrow mesenchymal
stem cell transplantation in liver failure patients caused by hepatitis B: Short-term
and long-term outcomes. Hepatology. 2011; 54(3): 820-828. doi:
10.1002/hep.24434.
50. Mohamadnejad M, Alimoghaddam K, Bagheri M, et al. Randomized
placebo-controlled trial of mesenchymal stem cell transplantation in
decompensated cirrhosis. Liver Int. 2013 Nov; 33(10): 1490-6. doi:
10.1111/liv.12228.
